A stable fixed-dose combination tablet of pseudoephedrine and KOB extracts for the extended release

Drug Research

Volumn 63, Issue 11, 2013, Pages 572-578

  Hwang, C J ^a   Park, M H ^a   Jung, H W ^b   Park, Y K ^b   Kim, Y H ^a   Kang, J S ^a   Cho, C W ^a  

^a Chungnam National University   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

allergic rhinitis; extended release; fixed dose combination; KOB extracts; pseudoephedrine

Indexed keywords

ATRACTYLODES MACROCEPHALA EXTRACT; BAICALIN; EXCIPIENT; OSTERICUM KOREANUM EXTRACT; PSEUDOEPHEDRINE; SAPOSHNIKOVIA DIVARICATA EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ALLERGIC RHINITIS; ARTICLE; ASTRAGALUS MEMBRANACEUS; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; EXTENDED DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAST CELL; PREFORMULATION; TABLET FORMULATION;

DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; FLAVONOIDS; PLANT EXTRACTS; PSEUDOEPHEDRINE; RHINITIS, ALLERGIC, PERENNIAL; SOLUBILITY; TABLETS;

EID: 84888860168     PISSN: 21949379     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0033-1348222     Document Type: Article

References (29)

1. Bousquet J., Khaltaev N. eds. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva, Switzerland World Health Organization: 2007; 1 155
2. Sly R. M. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol: 1999; 82 233 248
3. Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy: 1998; 28 3 10
4. Bauchau V., Durham S. R. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J: 2004; 24 758 764 (Pubitemid 39504428)
5. Janson C., Anto J., Burney P. et al. The European Community Respiratory Health Survey II. What are the main results so far? European Health Survey II. Eur Respir J: 2001; 18 598 611 (Pubitemid 32895647)
6. Sibbald B., Rink E. Labelling of rhinitis and hayfever by doctors. Thorax: 1991; 46 378 381
7. Lee Y. L., Shaw C. K., Su H. J. et al. Climate, traffic-related air pollutants and allergic rhinitis prevalence in middle-school children in Taiwan. Eur Respir J: 2003; 21 964 970
8. Grubbe R. E., Lumry W. R., Anolik R. Efficacy and Safety of Desloratadine/Pseudoephedrine Combination vs Its Components in Seasonal Allergic Rhinitis. J Investig Allergol Clin Immunol: 2009; 19 117 124
9. Canonica G. W., Bousquet J., Mullol J. et al. A survey of the burden of allergic rhinitis in Europe. Allergy: 2007; 62 17 25 (Pubitemid 47561569)
10. Pradalier A., Neukirch C., Dreyfus I. et al. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy: 2007; 62 1331 1334 (Pubitemid 47537496)
11. Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. Allergy: 2001; 56 14 20 (Pubitemid 32156193)
12. Jung H. W., Jung J. K., Cho C. W. et al. Antiallergic effect of KOB03, a polyherbal medicine, on mast cell-mediated allergic response in ovalbumin-induced allergic rhinitis mouse and human mast cells. J Ethnopharmacol: 2012; 142 684 693
13. Heo J. Dongui Bogam, Dae Sung Publisher Co., Seoul, Republic of Korea. 1985; 123
14. Kim C. M., Heo M. Y., Kim H. P. et al. Pharmacological activities of water extracts of Umbelliferae plants. Arch Pharm Res: 1991; 14 87 92
15. Na H. J., Jeong H. J., Hwang C. Y. et al. Effect of Boo Yong-Tang on mast cell-mediated allergic reaction. Immunopharm Immunotoxicol: 2004; 26 445 454
16. Shin S. In vitro effects of essential oils from Ostericum koreanum against antibiotic-resistant Salmonella spp. Arch Pharm Res: 2005; 28 765 769 (Pubitemid 43080152)
17. th ed. New York McGraw-Hill Companies, Inc: 2006; 260 262
18. Ellsworth A. J., Oliver L. M. Mosby's Medical Drug Reference. 2007 ed. Philadelphia, PA Elsevier Mosby: 2007; 988 989
19. Kanfer I., Dowse R., Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy: 1993; 13 6 Pt 2 116 128 discussion 143-146
20. Chua S. S., Benrimoj S. I., Triggs E. J. Pharmacokinetics of Non-Prescription Sympathomimetic Agents. Biopharm Drug Dispos: 1989; 10 1 14 (Pubitemid 19034498)
21. Simons F. E., Gu X., Watson W. T. et al. Pharmacokinetics of the Orally Administered Decongestants Pseudoephedrine and Phenylpropanolamine in Children. J Pediatr: 1996; 129 729 734 (Pubitemid 27498284)
22. Boyle S. P., Doolan P. J., Andrews C. E. et al. Evaluation of quality control strategies in Scutellaria herbal medicines. J Pharm Biomed Analysis: 2011; 54 951 957
23. Gao R., Zheng Q., Gong T. et al. Gradient high-performance liquid chromatography for the simultaneous determination of chlorogenic acid and baicalin in plasma and its application in the study of pharmacokinetics in rats. J Pharm Biomed Analysis: 2007; 43 335 340 (Pubitemid 44856192)
24. Shikai Yan S., Luo G., Wang Y. et al. Simultaneous determination of nine components in Qingkailing injection by HPLC/ELSD/DAD and its application to the quality control. J Pharm Biomed Analysis: 2006; 40 889 895 (Pubitemid 43257892)
25. Korean Food and Drug Association Notes 2007-14
26. Palma S. D., Manzo R. H., Allemandi D. A. Dry plant extracts loaded on fumed silica for direct compression: Preparation and preformulation. Pharm Dev Technol: 1999; 4 523 530 (Pubitemid 29536072)
27. Dodda S. R., Boggrapu P. R. Development and in Vitro-in Vivo Evaluation of Controlled Release Matrix Tablets of Desvenlafaxine. Pharmacology & Pharmacy: 2012; 3 15 19
28. Mohamed F. A., Roberts M., Seton L. et al. Production of extended release mini-tablets using directly compressible grades of HPMC. Drug Dev Ind Pharm: 2012; [Epub ahead of print]
29. Campos-Aldrete M. E., Villafuerte-Robles L. Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur J Pharm Biopharm: 1997; 43 173 178 (Pubitemid 28298798)